KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Roch Houot, Olalekan O. Oluwole et al.|The Lancet|2021

Cited by 795